The genome of avian leukemia virus E26 shares homology with v-myb, the oncogene of avian myeloblastosis virus, and encodes a protein with an Mr of 135,000. Analyses of tryptic oligopeptides show that this protein is related to the proteins encoded by gag (Pr769ag) as well as v-myb (p45v-myb [AMv]) and c-myb (p75-myb). We found no evidence for the existence of additional myb-related proteins or subgenomic species of myb-related RNA in myeloblasts transformed by strain E26.
Leukemia virus E26 is a replication-defective oncogenic retrovirus whose genome shares nucleotide sequences with v-myb, the oncogene of avian myeloblastosis virus (AMV) (19) . The oncogenic properties and the organization of the genomes of AMV and E26 differ considerably, however. AMV causes exclusively myeloblastic leukemia in chickens and transforms only cells of the myelomonocytic lineage in vitro (13) . In contrast, E26 typically induces a mixed erythroblastic and myeloblastic leukemia in chickens and quails and transforms immature cells of both the erythroid and myelomonocytic lineages in vitro (8, 14, 15, 18) . In addition, transformation of quail fibroblasts by strain E26 has been observed previously (7) .
In AMV v-myb resides at the 3' end of the viral polymerase gene between short remnants of the viral envelope gene (9, 20) . v-myb encodes a protein with an Mr of 45,000, p45v-m b(AMV) that is translated from a subgenomic mRNA (2, 3, 6, 10) . In contrast, the genome organization of strain E26 can be represented schematically as U5-tAgag-myb-etsAenv-U3 (1, 12, 16) . The existence of ets, a stretch of cellderived nucleotide sequence unrelated to known retroviral oncogenes, has been demonstrated by molecular cloning of the E26 genome and by nucleotide sequence analysis (12, 16) . On the basis of the analysis of gag-related proteins present in E26-transformed cells, Bister et al. concluded that E26 encodes a gag-myb-ets fusion protein, p135, with an Mr of 135,000 (1) . The lack of suitable serological reagents, however, has impeded characterization of this protein. Furthermore, the possible existence of additional myb-or etsencoded polypeptides specific for E26 has not been examined.
We analyzed the expression of myb-related nucleotide sequences of E26 by using a myb-specific antiserum characterized recently (10 analyzed by agarose gel electrophoresis, Northern blotting, and hybridization to radiolabeled myb-specific DNA probe. In parallel we analyzed polyadenylated RNA prepared from myeloblasts transformed by AMV and erythroblasts transformed by avian erythroblastosis virus (AEV). AMV-transformed myeloblasts contain high levels of genomic as well as subgenomic AMV RNA (3, 6) . AEV-transformed erythroblasts were chosen as a source of c-myb mRNA since they express high levels of this RNA (5). The resulting autoradiograph ( Fig. 1) shows that E26-transformed myeloblasts (lane 1) contain only one species of polyadenylated RNA that has detectable homology to myb. The size of this RNA (ca. 6.0 kilobases [kb] ) is different from that of any of the known species of v-myb RNA (Fig. 1, lane 2) or c-myb RNA (lane 3). The size of the E26 genome is known to be ca. 5.6 kb (1) . We therefore assume that the 6.0-kb RNA species visible in Fig. 1 , lane 1 is the genome of E26. The absence of additional bands indicates that no abundant subgenomic myb-related RNA is produced in E26-transformed myeloblasts.
To examine myb-related proteins specific for E26 we prepared radiolabeled extracts of E26-transformed myeloblasts and immunoprecipitated proteins with antiserum directed against the gag-encoded protein p19 (17) or with antiserum raised against a myb-encoded polypeptide synthesized in bacteria (10) . Only one protein with an apparent molecular weight of ca. 135,000 reacted with gag-specific serum (Fig. 2, lane 1) and with myb-specific serum (lane 3) but not with normal rabbit serum (lane 2). We assume that this protein is identical to the putative transforming protein of strain E26, p135, that has been described previously (1), and we therefore refer to this protein as p135gag-myb-ets. We substantiated this conclusion by demonstrating the presence of p135gag-myb-ets among the products of cell-free translation of polyadenylated viral RNA that had been isolated from virion particles harvested from the culture medium of E26-transformed myeloblasts (data not shown). We see no evidence for the existence of additional myb-related proteins in E26-transformed myeloblasts. Some faint bands that correspond to proteins with molecular weights of more than 200,000 are visible in lane 3 of Fig. 2 , but they were not observed consistently. The intense band at ca. 32,000 daltons represents nonspecific immunoprecipitation since its precipitation was independent of the antiserum used. Additional proteins immunoprecipitated with anti-p19 serum probably represent polypeptides encoded by the gag or gag and pol genes of helper virus.
The protein encoded by v-myb has recently been identified (5, 21) . RNA was then hybridized to DNA probe specific for the first two of the seven identified exons of the chicken c-myb gene (the 1.5-kb EcoRIISacl fragment of c-myb clone pCM1 [9] ). The approxi- in extracts of myeloblasts transformed by AMV as a protein with an Mr of 45,000 (2, 10). The product of the chicken c-myb gene has been identified in extracts of AEV-transformed erythroblasts (10) methionine-containing tryptic peptides of p135g"g-rnvb-ems, pr76gag p45v-myb(AMV) and p75c-mYb (Fig. 3) . We detected four tryptic peptides that are shared by p135gag-mYb-ets and Pr76gag (labeled with letters in Fig. 3 ) and two tryptic peptides that are shared by p135gag-myb-ets and both p45v-myb(AMV) and p75c-myb (labeled with numbers in Fig. 3 ).
This finding constitutes a direct demonstration of the presence of both gag-and myb-derived amino acid sequences in p135gag-myb-ets* The map of p135gag-myb-ets reveals a number of oligopeptides whose origins are not yet clear. They may be encoded by the nucleotide sequences designated as ets. Alternatively, they may be derived from gag-or myb-related nucleotide sequences that have suffered nucleotide substitutions in strain E26. One of the tryptic peptides shared by p135gag-myb-es and Pr76 is also present in tryptic digests of p45v-m b(AMv) but is not shared by p75c-mb (labeled with an asterisk in Fig. 3 ). The existence of this peptide is in accord with our previous conclusion that translation of p45v-m b(AMv) is initiated at the gag-AUG codon present on the leader region of subgenomic v-myb mRNA (10) . Thus, both p45v-mYb(AMv) and pI35gag-myb-e's appear to be gag-myb fusion proteins. The apparent amounts of gag-related amino acid sequences present in both proteins differ considerably, however, and fusion of gag-and myb-related coding regions is achieved by different means in AMV (post-transcriptionally by RNA splicing) than in E26. An obvious problem for future research is the question of whether the difference in the amount of amino acid sequences derived from the viral gag gene, the existence of an additional ets domain in p135ga-m 'b-e,S or the possible existence of an additional etsencoded protein constitutes the basis for the different oncogenic properties of E26 and AMV. extracts by immunoprecipitation and preparative gel electrophoresis. The proteins were digested with trypsin, and the resulting oligopeptides were then fractionated by electrophoresis and chromatography on cellulose-thin layer plates as described previously (10 
